Question 1

What is Annamycin?

Accepted Answer

Annamycin is a Other.

Question 2

How often does Annamycin appear in global news?

Accepted Answer

Tracked across 1 news events drawn from 7 articles.

Question 3

When was Annamycin first tracked by Ergen?

Accepted Answer

First tracked on May 21, 2026.

Question 4

When was Annamycin last mentioned in news?

Accepted Answer

Last active on May 29, 2026.

Question 5

What is Annamycin's current news sentiment?

Accepted Answer

Aggregate sentiment score: 75 on a -100 to +100 scale (negative = critical coverage, positive = favorable coverage).

Question 6

How prominent is Annamycin in global news coverage?

Accepted Answer

Attention score of 4, derived from article volume and coverage intensity across 1 events.

Question 7

What is the most recent event involving Annamycin?

Accepted Answer

Moleculin Annamycin Cardiac Safety Data (May 21, 2026, 7 articles).

Question 8

How did the "Moleculin Annamycin Cardiac Safety Data" event impact Annamycin?

Accepted Answer

Annamycin, Moleculin Biotech's lead drug candidate, demonstrated no detectable cardiotoxicity in a pooled analysis, suggesting it could overcome a major limitation of conventional anthracyclines in cancer treatment.

Question 9

How is this data collected?

Accepted Answer

Ergen aggregates thousands of global news sources and extracts structured events, entities, and relationships with sentiment and attention metrics. Pages are daily static snapshots from the platform's live database.